作者: Christopher J. Hoffmann , Joel E. Gallant
DOI: 10.1016/J.IDC.2014.08.003
关键词:
摘要: ndividual health benefits of antiretroviral therapy (ART) are becoming clearer. In resource-rich countries, side effects current ART regimens minimal. US guidelines recommend regardless CD4 count or viral load. Maintaining an undetectable load with comes close to eliminating the risk HIV transmission, leading universal reduce transmission. Achieving population-level control through treatment as prevention (TasP) may be feasible, but requires considerable investment resources devoted testing, linkage care, accessibility, and retention in care. Ongoing studies TasP will provide insight into achieving meaningful coverage.